InvestorQ : What is the latest status on the COVID vaccine proposed to be brought out by Bharat Biotech?
diksha shah made post

What is the latest status on the COVID vaccine proposed to be brought out by Bharat Biotech?

Answer
image
swati Bakhda answered.
1 month ago
Follow

When COVAXIN, the only purely indigenous vaccine from Bharat Biotech, got the approval for emergency administration as a COVID vaccine, there was a furore over the lack of clinical test data. Now the data is available in the public domain. The chairman of Bharat Biotech, Sridhar Ella, has confirmed that India’s home grown COVID vaccine, COVAXIN, has shown interim vaccine efficacy of 81% in late-stage clinical trials.

The good thing is that this is a lot better and also more encouraging than the original guidance given by the company which was an efficacy of approximately 60%. That is the figure the company had given last year but obviously, it has tweaked and fine-tuned its product since then. In the largest trial conducted in India, over 25,800 participants were involved. This included 2433 persons over 60 year and 4500 with existing comorbidities.

Based on the tests, COVAXIN of Bharat Biotech has demonstrated high clinical efficacy trend against COVID-19. It has also shown immunogenicity against variants, which means that it would be effective on the kind of virus mutations that we recently saw in UK and other parts of Europe. Participants received vaccine or placebo in 1:1 ratio, showing vaccine candidate was well tolerated. COVAXIN was approved by the SEC in Jan-21.

1 Views